Science

This photo released Thursday, July 2, 2020, by the Atomic Energy Organization of Iran shows a building after it was damaged by a fire at the Natanz uranium enrichment facility, some 200 miles (322 kilometers) south of the capital Tehran, Iran. Iran on Sunday confirmed that a damaged building at the underground Natanz nuclear site was a new centrifuge assembly center, the official IRNA news agency reported. (Atomic Energy Organization of Iran via AP, File)
July 02, 2020 - 9:26 am
DUBAI, United Arab Emirates (AP) — A fire and an explosion struck a building above Iran's underground Natanz nuclear enrichment facility early on Thursday, a site that U.S.-based analysts identified as a new centrifuge production plant. The Atomic Energy Organization of Iran sought to downplay the...
Read More
FILE — In this June 2, 2020 file photo, a demonstrator holds a placard during a protest against the tobacco ban outside parliament in Cape Town, South Africa. South Africa is three months into a ban on the sale of cigarettes and other tobacco products, an unusual tactic employed by a government to protect the health of its citizens during the coronavirus pandemic. The country is one of just a few around the world to have banned tobacco sales during the pandemic and the only one to still have it in place. (AP Photo/Nardus Engelbrecht/File)
July 02, 2020 - 6:29 am
CAPE TOWN, South Africa (AP) — The message was dropped into a WhatsApp group used by suburban moms in South Africa. Amid the grumblings over homeschooling during lockdown, one mom went off topic: “Does anyone know where to get illegal cigarettes? I just need a few. I'm desperate.” She emphasized...
Read More
FILE - In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday, July 1, 2020. (University of Maryland School of Medicine via AP)
July 01, 2020 - 10:13 am
The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday. Study volunteers given either a low or medium dose, in two shots about a month apart, had immune...
Read More
FILE - In this Saturday, June 6, 2020 file photo, demonstrators gather near the White House in Washington, to protest the death of George Floyd, a black man who was in police custody in Minneapolis. Public health experts say there is little evidence that the protests that erupted after Floyd’s death caused a significant increase in coronavirus infections. If the protests had driven an explosion in cases, experts say, the jumps would have started to become apparent within two weeks — and perhaps as early as five days. (AP Photo/Jacquelyn Martin)
July 01, 2020 - 10:12 am
NEW YORK (AP) — There is little evidence that the protests that erupted after George Floyd’s death caused a significant increase in U.S. coronavirus infections, according to public health experts. If the protests had driven an explosion in cases, experts say, the jumps would have started to become...
Read More
A vaccine volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg Wednesday, June 24, 2020. Africa’s first participation in a COVID-19 vaccine trial has begun as volunteers received injections developed at the University of Oxford in Britain. The large-scale trial is being conducted in South Africa, Britain and Brazil. (AP Photo/Siphiwe Sibeko)
July 01, 2020 - 5:46 am
JOHANNESBURG (AP) — A protest against Africa’s first COVID-19 vaccine trial was underway Wednesday as experts note a worrying level of resistance and misinformation around testing on the continent. Anti-vaccine sentiment in Africa is “the worst I’ve ever seen,” the CEO of the GAVI vaccine alliance...
Read More
House Speaker Nancy Pelosi of Calif., speaks at a news conference on Capitol Hill in Washington, Friday, June 26, 2020. (AP Photo/Carolyn Kaster)
June 30, 2020 - 4:55 pm
WASHINGTON (AP) — House Democrats on Tuesday unveiled a plan to address climate change that would set a goal of net-zero greenhouse gas emissions by 2050, while pushing renewable energy such as wind and solar power and addressing environmental contamination that disproportionately harms low-income...
Read More
Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, testifies before a Senate Health, Education, Labor and Pensions Committee hearing on Capitol Hill in Washington, Tuesday, June 30, 2020. (Kevin Dietsch/Pool via AP)
June 30, 2020 - 1:40 pm
WASHINGTON — Dr. Anthony Fauci said coronavirus cases could grow to 100,000 a day in the U.S. if Americans don’t start following public health recommendations. The nation’s leading infectious disease expert made the remark at a Senate hearing on reopening schools and workplaces. Asked to forecast...
Read More
FILE - In this Friday, May 15, 2020 file photo, people line up for coronavirus testing at a large factory in Wuhan in central China's Hubei province. In June 2020, China reported using batch testing as part of a recent campaign to test all 11 million residents of Wuhan, the city where the virus first emerged late in late 2019. (Chinatopix Via AP)
June 30, 2020 - 11:08 am
WASHINGTON (AP) — The nation's top health officials are banking on a new approach to dramatically boost U.S. screening for the coronavirus: combining test samples in batches instead of running them one by one. The potential benefits include stretching laboratory supplies, reducing costs and...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
June 29, 2020 - 10:54 am
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for...
Read More
FILE - In this Thursday, May 7, 2020 file photo, a pregnant woman wearing a face mask and gloves holds her belly as she waits in line for groceries with hundreds during a food pantry sponsored by Healthy Waltham for those in need due to the COVID-19 virus outbreak, at St. Mary's Church in Waltham, Mass. On Thursday, June 25, 2020, the Centers for Disease Control and Prevention updated its list of which Americans are at higher risk for severe cases of COVID-19, adding pregnant women and removing age alone as a factor. (AP Photo/Charles Krupa)
June 25, 2020 - 4:12 pm
NEW YORK (AP) — The nation's top public health agency on Thursday revamped its list of which Americans are at higher risk for severe COVID-19 illness, adding pregnant women and removing age alone as a factor. The Centers for Disease Control and Prevention also changed the list of underlying...
Read More

Pages